ANVISA: regulatory trends for 2026

ANVISA continues to harmonize with PIC/S and EU GMP, with direct impacts on the design of injectable and solid lines. Projects with SHINVA and SMA technology already deliver, by default, the required pressurization, segregation and traceability requirements, reducing the regulatory risk of new investments.